Elkhorn Investments LLC Has $1.31 Million Position in UnitedHealth Group (UNH)

Elkhorn Investments LLC increased its position in shares of UnitedHealth Group (NYSE:UNH) by 10.9% in the 4th quarter, HoldingsChannel reports. The firm owned 6,704 shares of the healthcare conglomerate’s stock after purchasing an additional 661 shares during the period. Elkhorn Investments LLC’s holdings in UnitedHealth Group were worth $1,306,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Highland Private Wealth Management increased its holdings in UnitedHealth Group by 0.4% in the second quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after buying an additional 13 shares in the last quarter. Intellectus Partners LLC increased its holdings in UnitedHealth Group by 18.2% in the second quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $152,000 after buying an additional 126 shares in the last quarter. M&R Capital Management Inc. increased its holdings in UnitedHealth Group by 14.8% in the second quarter. M&R Capital Management Inc. now owns 1,550 shares of the healthcare conglomerate’s stock valued at $299,000 after buying an additional 200 shares in the last quarter. Capital Investment Advisors LLC increased its holdings in UnitedHealth Group by 4.2% in the fourth quarter. Capital Investment Advisors LLC now owns 5,381 shares of the healthcare conglomerate’s stock valued at $1,186,000 after buying an additional 217 shares in the last quarter. Finally, Osborn Williams & Donohoe LLC increased its holdings in UnitedHealth Group by 1.6% in the fourth quarter. Osborn Williams & Donohoe LLC now owns 14,229 shares of the healthcare conglomerate’s stock valued at $3,137,000 after buying an additional 223 shares in the last quarter. 86.73% of the stock is owned by hedge funds and other institutional investors.

In related news, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, April 23rd. The shares were sold at an average price of $234.20, for a total transaction of $3,513,000.00. Following the sale, the director now owns 1,761,533 shares in the company, valued at $412,551,028.60. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Michele J. Hooper sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the sale, the director now owns 37,284 shares in the company, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 82,019 shares of company stock worth $18,928,333. 0.89% of the stock is owned by company insiders.

A number of research analysts have issued reports on UNH shares. Evercore ISI reaffirmed an “outperform” rating and issued a $255.00 target price (up from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a report on Saturday, January 20th. Goldman Sachs started coverage on shares of UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 target price for the company. Cantor Fitzgerald increased their target price on shares of UnitedHealth Group to $280.00 and gave the company an “overweight” rating in a report on Wednesday, January 17th. Finally, Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Friday, March 9th. Three analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $253.70.

Shares of NYSE UNH opened at $237.03 on Friday. UnitedHealth Group has a 1 year low of $166.65 and a 1 year high of $250.79. The company has a market cap of $225,103.41, a P/E ratio of 23.54, a PEG ratio of 1.35 and a beta of 0.77. The company has a current ratio of 0.71, a quick ratio of 0.73 and a debt-to-equity ratio of 0.56.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.91 by $0.13. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The firm had revenue of $55.19 billion for the quarter, compared to analyst estimates of $54.90 billion. During the same quarter last year, the business earned $2.37 earnings per share. UnitedHealth Group’s revenue was up 13.3% compared to the same quarter last year. sell-side analysts anticipate that UnitedHealth Group will post 12.61 earnings per share for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply